Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Carmen Monaco"'
Publikováno v:
Physical Review Research, Vol 3, Iss 3, p 033137 (2021)
Van der Waals heterostructures assembled from atomically thin crystals are ideal model systems to study spin-orbital coupled transport because they exhibit a strong interplay between spin, lattice, and valley degrees of freedom that can be manipulate
Externí odkaz:
https://doaj.org/article/80f78b3ab5484f56a02dd13cf88c9801
van der Waals heterostructures assembled from atomically thin crystals are ideal model systems to study spin-orbital coupled transport because they exhibit a strong interplay between spin, lattice and valley degrees of freedom that can be manipulated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::271b41a07a59bf41402f986f5f051ea7
Autor:
Daniela Califano, A. Mineo, V de Franciscis, Giancarlo Vecchio, Carmen Monaco, Giovanni Chiappetta, Giovanni Santelli
Publikováno v:
International Journal of Cancer. 63:757-760
We have earlier shown that expression of the human activated Ki-ras, directed by the rat thyroglobulin CTG) promoter in the thyroid gland of transgenic mice, is able to induce thyroid benign tumors, albeit at low incidence. A likely explanation of ou
Autor:
Ilaria Le Pera, Irene Samà, Lorenzo Chiariotti, Marialuisa Martelli, Simona Cammarota, Alfredo Fusco, Carmen Monaco, Todd G. Kroll, Massimo Santoro, Rodolfo Iuliano
Publikováno v:
87 (2002): 4728–4735.
info:cnr-pdr/source/autori:Martelli M.L. 1, Iuliano R. 1, Le Pera I. 1, Sama' I.1, Monaco C. 2, Cammarota S. 2, Kroll T. 3, Chiariotti L. 1, Santoro M. 2, Fusco A. 1-2/titolo:Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growth./doi:/rivista:/anno:2002/pagina_da:4728/pagina_a:4735/intervallo_pagine:4728–4735/volume:87
info:cnr-pdr/source/autori:Martelli M.L. 1, Iuliano R. 1, Le Pera I. 1, Sama' I.1, Monaco C. 2, Cammarota S. 2, Kroll T. 3, Chiariotti L. 1, Santoro M. 2, Fusco A. 1-2/titolo:Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growth./doi:/rivista:/anno:2002/pagina_da:4728/pagina_a:4735/intervallo_pagine:4728–4735/volume:87
Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a nuclear receptor involved in such cellular processes as adipogenesis, inflammation, atherosclerosis, cell cycle control, apoptosis, and carcinogenesis. PPAR gamma gene mutations have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0204113b18a27aea8f2e68cff09a3262
http://hdl.handle.net/11588/470256
http://hdl.handle.net/11588/470256
Autor:
Chaline Johnson, Mauro Papotti, Ginesa Garcia-Rostan, Massimo Santoro, Carmen Monaco, Giovanni Tallini, Francesca Pentimalli, Robert L. Camp, Gennaro Chiappetta, Alfredo Fusco, Agustin Herrero, Maria Luisa Carcangiu, Marco Volante
Publikováno v:
87 (2002): 370–379.
info:cnr-pdr/source/autori:Santoro M. 1, Papotti M. 2, Chiappetta G. 3, Garcia-Rostan G. 4, Volante M. 2, Johnson C., Camp R.L. 6, Pentimalli F. 1, Monaco C. 1, Herrero A. 2, Carcangiu M.l. 5, Fusco A. 1, Tallini G. 6/titolo:RET activation and clinicopathologic features in poorly differentiated thyroid tumors./doi:/rivista:/anno:2002/pagina_da:370/pagina_a:379/intervallo_pagine:370–379/volume:87
info:cnr-pdr/source/autori:Santoro M. 1, Papotti M. 2, Chiappetta G. 3, Garcia-Rostan G. 4, Volante M. 2, Johnson C., Camp R.L. 6, Pentimalli F. 1, Monaco C. 1, Herrero A. 2, Carcangiu M.l. 5, Fusco A. 1, Tallini G. 6/titolo:RET activation and clinicopathologic features in poorly differentiated thyroid tumors./doi:/rivista:/anno:2002/pagina_da:370/pagina_a:379/intervallo_pagine:370–379/volume:87
Poorly differentiated carcinoma of the thyroid gland (PDC) represents an heterogeneous group of epithelial neoplasms with morphologic features and clinical characteristics intermediate between well differentiated and anaplastic (undifferentiated) car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0a8346be72868a2d2ab8a28a9053159
http://www.cnr.it/prodotto/i/20905
http://www.cnr.it/prodotto/i/20905
Autor:
Massimo Santoro, Fulvio Basolo, Aldo Pinchera, Luca Pollina, Furio Pacini, Carmen Monaco, Paolo Miccoli, Gennaro Chiappetta, Alfredo Fusco, Eleonora Molinaro, Rossella Elisei, Marco Capezzone, Laura Agate
Publikováno v:
Scopus-Elsevier
BACKGROUND: RET proto-oncogene rearrangements (RET/PTC) are causative events in the pathogenesis of a subset of papillary thyroid cancer (PTC). The prevalence of RET/PTC varies in different countries and according to specific clinical features: it is
Autor:
Rosa Marina Melillo, Giovanni Santelli, A. Mineo, Leandra Sepe, Massimo Santoro, Carmen Monaco, Alfredo Fusco, Donatella Tramontano, Maria Vittoria Barone, Maria Domenica Castellone
Publikováno v:
Oncogene (Basingstoke) 20 (2001): 6973–6982.
info:cnr-pdr/source/autori:Barone M.V. 1, Sepe L. 2, Melillo R.M. 1, Mineo A. 2, Santelli G. 2, Monaco C. 1, Castellone M.D. 1, Tramontano D. 3, Fusco A. 1, Santoro M. 1/titolo:RET%2FPTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho./doi:/rivista:Oncogene (Basingstoke)/anno:2001/pagina_da:6973/pagina_a:6982/intervallo_pagine:6973–6982/volume:20
info:cnr-pdr/source/autori:Barone M.V. 1, Sepe L. 2, Melillo R.M. 1, Mineo A. 2, Santelli G. 2, Monaco C. 1, Castellone M.D. 1, Tramontano D. 3, Fusco A. 1, Santoro M. 1/titolo:RET%2FPTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho./doi:/rivista:Oncogene (Basingstoke)/anno:2001/pagina_da:6973/pagina_a:6982/intervallo_pagine:6973–6982/volume:20
Thyroid papillary carcinomas are characterized by RET/PTC rearrangements that cause the tyrosine kinase domain of the RET receptor to fuse with N-terminal sequences encoded by heterologous genes. This results in the aberrant expression of a ligand-in
Autor:
Alfredo Fusco, Giovanna Maria Pierantoni, Claudia De Lorenzo, Maria Terasa Berlingieri, Carmen Monaco, Giancarlo Vecchio, Roberta Visconti, Maria Vittoria Barone, A. Mineo, Massimo Santoro
Publikováno v:
Oncogene (Basingstoke) 20 (2001): 599–608.
info:cnr-pdr/source/autori:Monaco C; Visconti R; Barone MV; Pierantoni GM; Berlingieri MT; De Lorenzo C; Mineo A; Vecchio G; Fusco A; Santoro M/titolo:The RFG oligomerization domain mediates kinase activation and re-localization of the RET%2FPTC3 oncoprotein to the plasma membrane/doi:/rivista:Oncogene (Basingstoke)/anno:2001/pagina_da:599/pagina_a:608/intervallo_pagine:599–608/volume:20
info:cnr-pdr/source/autori:Monaco C; Visconti R; Barone MV; Pierantoni GM; Berlingieri MT; De Lorenzo C; Mineo A; Vecchio G; Fusco A; Santoro M/titolo:The RFG oligomerization domain mediates kinase activation and re-localization of the RET%2FPTC3 oncoprotein to the plasma membrane/doi:/rivista:Oncogene (Basingstoke)/anno:2001/pagina_da:599/pagina_a:608/intervallo_pagine:599–608/volume:20
The RET/PTC3 oncogene arises from the fusion between the N-terminal encoding domain of the RFG gene and the tyrosine kinase encoding domain of RET receptor. RET/PTC3 is very frequent in papillary thyroid carcinomas, especially in children exposed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::842fd2dd31dd02dd85bc3eed4de48407
http://www.cnr.it/prodotto/i/20855
http://www.cnr.it/prodotto/i/20855
A dimeric mutant of human pancreatic ribonuclease with selective cytotoxicity toward malignant cells
Autor:
Daniela Spalletti-Cernia, Giuseppe D'Alessio, Renata Piccoli, Michela Grauso, Jaroslav Cinátl, Carmen Monaco, Sonia Di Gaetano, Claudia De Lorenzo, Paolo Laccetti, Josef Matoušek
Monomeric human pancreatic RNase, devoid of any biological activity other than its RNA degrading ability, was engineered into a dimeric protein with a cytotoxic action on mouse and human tumor cells, but lacking any appreciable toxicity on mouse and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7679039647dbede340426e3f8033cb1d
http://hdl.handle.net/11588/147212
http://hdl.handle.net/11588/147212
Autor:
Mauro Helmer Citterich, Massimo Negrini, Giandomenico Russo, Igor Vorechovsky, Carmen Monaco, Giuseppe Barbanti-Brodano, Elisabetta Caprini, Carlo M. Croce
Publikováno v:
Genomics. 52(3)
Two distinct regions of loss of heterozygosity (LOH) in breast carcinomas were previously identified at chromosome 11q23. With the aim of identifying a tumor suppressor gene, we undertook the isolation and characterization of genes within LOH region